Register | Login | Help |
 
SEARCH PATENT INVENTORS:
First name

Last name
City/State

Charles D. Y. Sia

City: Thornhill
State/Country: CA

Are you Charles D. Y. Sia?

CLAIM YOUR PROFILE NOW:

Distinguish yourself and attract new opportunities
Update and enhance your profile with information,           uploaded documents, and video
Request recommendations to boost your profile.
 
Companies
Sanofi Pasteur Limited - Toronto CA

Sanofi Pasteur Limited - Toronto Ontario US


Patents
US7220826 - Expressing gp140 fragment of primary HIV-1 isolate -  05/22/2007 
A vector for eliciting an immune response to a host comprising a gene encoding the gp140 protein of the primary isolate of HIV-1, BX08, under the control of a promotor for expression of the protein in the host, specifically plasmids pCMV.gp140.BX08, pMP83, pMP84 and pMP88. Murine and human MHC class 1-restricted binding motifs contained in BX08 are identified.
US7220826 - Expressing gp140 fragment of primary HIV-1 isolate -  05/22/2007 
A vector for eliciting an immune response to a host comprising a gene encoding the gp140 protein of the primary isolate of HIV-1, BX08, under the control of a promotor for expression of the protein in the host, specifically plasmids pCMV.gp140.BX08, pMP83, pMP84 and pMP88. Murine and human MHC class 1-restricted binding motifs contained in BX08 are identified.
US7105164 - HIV-specific cytotoxic T-cell responses -  09/12/2006 
A method of generating an HIV-specific cytotoxic T-cell response in a host involves an initial administration of a T-helper molecule to the host to prime T-helper cells of the immune system of the host and a subsequent administration to the host of a mixture of the T-helper molecule and a T-cell inducing HIV-derived molecule to generate an HIV-specific T-cell response in the host.
US7105164 - HIV-specific cytotoxic T-cell responses -  09/12/2006 
A method of generating an HIV-specific cytotoxic T-cell response in a host involves an initial administration of a T-helper molecule to the host to prime T-helper cells of the immune system of the host and a subsequent administration to the host of a mixture of the T-helper molecule and a T-cell inducing HIV-derived molecule to generate an HIV-specific T-cell response in the host.
US6395714 - Expressing gp140 fragment of primary HIV-1 isolate -  05/28/2002 
A vector for eliciting an immune response to a host comprising a gene encoding the gp140 protein of the primary isolate of HIV-1, BX08, under the control of a promotor for expression of the protein in the host, specifically plasmid pCMV.gp140.BX08. Murine and human MHC class 1-restricted binding motifs contained in BX08 are identified.

view more

We are your best, most user-friendly source for searching patents and patent attorneys on the Internet.
Advanced Search | Expert Search | Browse Patent By Date | The Community | Exchange | About Patents.com
Login | Help | Contact Us | Terms of Use | Privacy Statement | Advertising | Site Map
Copyright 2008-09 Patents.com